Cargando…
Suppression of Breast Cancer Cell Proliferation by Selective Single-Domain Antibody for Intracellular STAT3
BACKGROUND: The serendipitous discovery of heavy-chain antibodies devoid of light chains in camelids and the subsequent development of VHHs (variable region of camelid heavy chain) have provided a very important tool for research and possibly for therapeutics. In this study, we synthesized single-do...
Autores principales: | Singh, Sunanda, Murillo, Genoveva, Chen, Dong, Parihar, Ashutosh S, Mehta, Rajendra G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802608/ https://www.ncbi.nlm.nih.gov/pubmed/29434474 http://dx.doi.org/10.1177/1178223417750858 |
Ejemplares similares
-
A Broad-Based Characterization of a Cell-Penetrating, Single Domain Camelid Bi-Specific Antibody Monomer That Targets STAT3 and KRAS Dependent Cancers
por: Singh, Sunanda, et al.
Publicado: (2022) -
STAT3-Specific Single Domain Nanobody Inhibits Expansion of Pathogenic Th17 Responses and Suppresses Uveitis in Mice
por: Mbanefo, Evaristus C., et al.
Publicado: (2021) -
Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition
por: Singh, Sunanda, et al.
Publicado: (2023) -
Antibodies in the intracellular domain
por: McEwan, William A.
Publicado: (2022) -
An Inside Job: Applications of Intracellular Single Domain Antibodies
por: Soetens, Eline, et al.
Publicado: (2020)